SCHEMBL7111154

SCHEMBL7111154

CCC(C)Nc1cc[c]cc1C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HSP90AA1 P07900 1/20 0.39
CYP3A4 P08684 1/20 0.39
THRB P10828 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
CASP1 P29466 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HIF1A Q16665 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7112683 0.83 PDE3B (0.36)
SCHEMBL7110018 0.77 PDE3B (0.36) CYP3A4TSHR
SCHEMBL7113956 0.76 TLR7 (0.40) ALDH1A1PTGS2
SCHEMBL7112341 0.74 PDE3B (0.38) ALDH1A1CYP1A2POLB
SCHEMBL9362925 0.72 TSHR (0.44) TP53L3MBTL1ALDH1A1HSP90AA1CYP3A4
SCHEMBL7113832 0.71 PDE3B (0.35)
SCHEMBL5217967 0.71 KMT2A (0.42) ALDH1A1CYP3A4THRBSMN1; SMN2MEN1
SCHEMBL27836346 0.70 SOS1 (0.43) MEN1KMT2A
SCHEMBL687401 0.70 POLB (0.45) ALDH1A1THRBTSHRMEN1KMT2A
SCHEMBL687471 0.69 POLB (0.47) ALDH1A1THRBTSHRSMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1351924-A2 DIAMINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Pharma Company (US) 2003-10-15 EP disclosed
WO-2002050019-A2 DIAMINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB PHARMA CO. (US) 2002-06-27 WO disclosed